SCHEMBL4733869

SCHEMBL4733869

COc1ccc(-c2ccnc(F)c2)cc1CNC1CCC(N(C)C(=O)OC(C)(C)C)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 4/20 0.37
TACR1 P25103 1/20 0.35
KCNH2 Q12809 1/20 0.35
PDE4B Q07343 1/20 0.35
CDK9 P50750 4/20 0.35
CCNT1 O60563 3/20 0.35
CDK1 P06493 2/20 0.35
CDK2 P24941 2/20 0.35
CDK3 Q00526 2/20 0.35
CDK5 Q00535 2/20 0.35
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
CCNB1 P14635 1/20 0.35
CCNE1 P24864 1/20 0.35
CCNA1 P78396 1/20 0.35
CDK5R1 Q15078 1/20 0.35
PIK3CD O00329 1/20 0.35
KAT6A Q92794 1/20 0.35
KAT8 Q9H7Z6 1/20 0.35
NTRK1 P04629 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12678663 1.00 AAK1 (0.37) AAK1TACR1KCNH2PDE4BCDK9
SCHEMBL12678432 0.91 WNT3A (0.38) AAK1TACR1PIK3CDCYP3A4CYP2D6
SCHEMBL12678648 0.91 MEN1 (0.36) KCNH2PDE4BKAT6AKAT8NTRK1
SCHEMBL4730577 0.91 MEN1 (0.36) KCNH2PDE4BKAT6AKAT8NTRK1
SCHEMBL12690162 0.90 MEN1 (0.39) TACR1SCN9AMEN1KMT2A
SCHEMBL4891350 0.90 TACR1 (0.45) AAK1TACR1PDE4BPIK3CDMEN1
SCHEMBL12678720 0.90 TACR1 (0.45) AAK1TACR1PDE4BPIK3CDMEN1
SCHEMBL12678644 0.87 AAK1 (0.38) AAK1KCNH2PDE4BCDK9CCNT1
SCHEMBL4732703 0.87 AAK1 (0.38) AAK1KCNH2PDE4BCDK9CCNT1
SCHEMBL12678411 0.86 IRAK4 (0.37) AAK1TACR1PDE4BPIK3CDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120245184-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION ADERANS RESEARCH INSTITUTE, INC. 2012-09-27 US disclosed
US-8273747-B2 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin CURIS, INC. (US) 2012-09-25 US disclosed
US-20080193423-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080194637-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin CURIS, INC. (US) 2008-07-31 US disclosed
WO-2008057497-A2 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
WO-2008057469-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION WYETH (US) 2008-05-15 WO disclosed
WO-2008057468-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
US-20080058521-A1 Processes for the preparation of compounds WYETH (US) 2008-03-06 US disclosed
WO-2007089669-A2 PROCESSES FOR THE PREPARATION OF COMPOUNDS WHICH MODULATE CELL PROLIFERATION WYETH (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193423-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO AAK1 1370/4885TACR1 1166/4885KCNH2 3249/4885
US-20080058521-A1 Processes for the preparation of compounds MKI67, MCL1, DCX AAK1 3627/4885TACR1 1194/4885KCNH2 4601/4885
US-20120245184-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION GLI1, SHH, SMO AAK1 1370/4885TACR1 1166/4885KCNH2 3249/4885
US-20080194637-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO AAK1 1370/4885TACR1 1166/4885KCNH2 3249/4885
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin SHH, GLI1, SMO AAK1 704/4885TACR1 837/4885KCNH2 3674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.